BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 11360629)

  • 41. Dynamic expression of pepsinogen C in gastric cancer, precancerous lesions and Helicobacter pylori associated gastric diseases.
    Ning PF; Liu HJ; Yuan Y
    World J Gastroenterol; 2005 May; 11(17):2545-8. PubMed ID: 15849808
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
    Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
    Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
    Cao Q; Ran ZH; Xiao SD
    J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Helicobacter pylori infection and gastric cancer. A nested case-control study in a rural area of Japan.
    Watanabe Y; Kurata JH; Mizuno S; Mukai M; Inokuchi H; Miki K; Ozasa K; Kawai K
    Dig Dis Sci; 1997 Jul; 42(7):1383-7. PubMed ID: 9246033
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Helicobacter pylori-associated gastritis and gastric carcinoma in Beijing.
    Ji X; Shen M; Jia P; Long X
    J Environ Pathol Toxicol Oncol; 1993; 12(4):209-12. PubMed ID: 8189377
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of Helicobacter pylori in gastric carcinoma.
    Prabhu SR; Amrapurkar AD; Amrapurkar DN
    Natl Med J India; 1995; 8(2):58-60. PubMed ID: 7735060
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The association between precancerous gastric lesions and serum pepsinogens, serum gastrin, vascular endothelial growth factor, serum interleukin-1 Beta, serum toll-like receptor-4 levels and Helicobacter pylori Cag A status.
    Yakut M; Örmeci N; Erdal H; Keskin O; Karayel Z; Tutkak H; Soykan I
    Clin Res Hepatol Gastroenterol; 2013 Jun; 37(3):302-11. PubMed ID: 23137754
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Environmental factors in Helicobacter pylori-related gastric precancerous lesions in Venezuela.
    Kato I; Vivas J; Plummer M; Lopez G; Peraza S; Castro D; Sanchez V; Cano E; Andrade O; Garcia R; Franceschi S; Oliver W; Muñoz N
    Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):468-76. PubMed ID: 15006925
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunoproteomics of Helicobacter pylori infection in patients with atrophic body gastritis, a predisposing condition for gastric cancer.
    Lahner E; Bernardini G; Possenti S; Renzone G; Scaloni A; Santucci A; Annibale B
    Int J Med Microbiol; 2011 Feb; 301(2):125-32. PubMed ID: 20843738
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic gastritis, intestinal metaplasia, dysplasia and Helicobacter pylori in gastric cancer: putting the pieces together.
    Dobrilla G; Benvenuti S; Amplatz S; Zancanella L
    Ital J Gastroenterol; 1994 Dec; 26(9):449-58. PubMed ID: 7599347
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of Helicobacter pylori infection and environmental factors in non-cardia gastric cancer in Japan.
    Machida-Montani A; Sasazuki S; Inoue M; Natsukawa S; Shaura K; Koizumi Y; Kasuga Y; Hanaoka T; Tsugane S
    Gastric Cancer; 2004; 7(1):46-53. PubMed ID: 15052440
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.
    Wong BC; Lam SK; Wong WM; Chen JS; Zheng TT; Feng RE; Lai KC; Hu WH; Yuen ST; Leung SY; Fong DY; Ho J; Ching CK; Chen JS;
    JAMA; 2004 Jan; 291(2):187-94. PubMed ID: 14722144
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential Helicobacter pylori infection rates in two contrasting gastric cancer risk regions of South China. China Gastric Cancer Study Group.
    Wong BC; Lam SK; Ching CK; Hu WH; Kwok E; Ho J; Yuen ST; Gao Z; Chen JS; Lai KC; Ong LY; Chen BW; Wang WH; Jiang XW; Hou XH; Lu JY
    J Gastroenterol Hepatol; 1999 Feb; 14(2):120-5. PubMed ID: 10029291
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Significance of Helicobacter pylori infection as a risk factor in gastric cancer: serological and histological studies.
    Barreto-Zuñiga R; Maruyama M; Kato Y; Aizu K; Ohta H; Takekoshi T; Bernal SF
    J Gastroenterol; 1997 Jun; 32(3):289-94. PubMed ID: 9213239
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Suicide journey of H. pylori through gastric carcinogenesis: the role of non-H. pylori microbiome and potential consequences for clinical practice.
    de Assumpção PP; Araújo TMT; de Assumpção PB; Barra WF; Khayat AS; Assumpção CB; Ishak G; Nunes DN; Dias-Neto E; Coelho LGV
    Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1591-1597. PubMed ID: 31114971
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inducible nitric oxide synthase, anti-oxidant enzymes and Helicobacter pylori infection in gastritis and gastric precancerous lesions in humans.
    Pignatelli B; Bancel B; Estève J; Malaveille C; Calmels S; Correa P; Patricot LM; Laval M; Lyandrat N; Ohshima H
    Eur J Cancer Prev; 1998 Dec; 7(6):439-47. PubMed ID: 9926291
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interaction between dietary factors and Helicobacter pylori infection in noncardia gastric cancer: a population-based case-control study in China.
    Wang XQ; Yan H; Terry PD; Wang JS; Cheng L; Wu WA; Hu SK
    J Am Coll Nutr; 2012 Oct; 31(5):375-84. PubMed ID: 23529995
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lessons learned from upper gastrointestinal endoscopy in asymptomatic Chinese.
    Huang Y; Li H; Long X; Liang X; Lu H
    Helicobacter; 2021 Jun; 26(3):e12803. PubMed ID: 33779026
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association between Gastric Pathology and Hepatitis B Virus Infection in Patients with or without Helicobacter Pylori.
    Baghbanian M; Hoseini Mousa SA; Doosti M; Moghimi M
    Asian Pac J Cancer Prev; 2019 Jul; 20(7):2177-2180. PubMed ID: 31350982
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors.
    You WC; Zhang L; Gail MH; Chang YS; Liu WD; Ma JL; Li JY; Jin ML; Hu YR; Yang CS; Blaser MJ; Correa P; Blot WJ; Fraumeni JF; Xu GW
    J Natl Cancer Inst; 2000 Oct; 92(19):1607-12. PubMed ID: 11018097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.